Toggle Sidebar
Home
AI Agent
Annotations
Watchlists
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
MRNA US
Moderna, Inc.
(MRNA US)
$200.10
-2.53
1.25%
Ext:
$201.34
+1.24
0.62%
(Market Closed · 00:00:05 UTC)
Follow
Financials & Metrics
Financials
Charting
Short Interest
Employees
SEC Filings
Select Filings
Financials
(32)
Expand
10-Q
Q2
ended 30 Jun 2026
31 Jul
10-Q
Q1
ended 31 Mar 2026
1 May
10-K
FY 2025
ended 31 Dec 2025
20 Feb
10-Q
Q3
ended 30 Sept 2025
6 Nov 2025
10-Q
Q2
ended 30 Jun 2025
1 Aug 2025
10-Q
Q1
ended 31 Mar 2025
1 May 2025
10-K
FY 2024
ended 31 Dec 2024
21 Feb 2025
10-Q
Q3
ended 30 Sept 2024
7 Nov 2024
10-Q
Q2
ended 30 Jun 2024
1 Aug 2024
10-Q
Q1
ended 31 Mar 2024
2 May 2024
10-K
FY 2023
ended 31 Dec 2023
23 Feb 2024
10-Q
Q3
ended 30 Sept 2023
3 Nov 2023
10-Q
Q2
ended 30 Jun 2023
3 Aug 2023
10-Q
Q1
ended 31 Mar 2023
4 May 2023
10-K
FY 2022
ended 31 Dec 2022
24 Feb 2023
Events
(117)
Expand
8-K
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
30 Sep
8-K
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
1 Sep
8-K
Results of Operations and Financial Condition
31 Jul
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
8 Jul
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
11 May
8-K
Results of Operations and Financial Condition
1 May
8-K
Entry into a Material Definitive Agreement
4 Mar
8-K
Results of Operations and Financial Condition
13 Feb
8-K
Regulation FD Disclosure
10 Feb
8-K
Results of Operations and Financial Condition
12 Jan
8-K
Regulation FD Disclosure
5 Jan
8-K
Entry into a Material Definitive Agreement
24 Nov 2025
8-K
Regulation FD Disclosure
20 Nov 2025
8-K
Submission of Matters to a Vote of Security Holders
13 Nov 2025
8-K
Results of Operations and Financial Condition
6 Nov 2025
Insider Ownership
(1.1K)
Expand
4
Hoge Stephen
16 Oct
4
Mock James M
7 Oct
3
Andres Juan
5 Oct
4
Hoge Stephen
16 Sep
4
Mock James M
14 Sep
4
Mock James M
8 Sep
4
Klinger Shannon Thyme
8 Sep
4
Klinger Shannon Thyme
3 Sep
4
Mock James M
3 Sep
4
Hoge Stephen
3 Sep
4
Hoge Stephen
31 Aug
4
Klinger Shannon Thyme
31 Aug
4
Mock James M
31 Aug
4
Bancel Stephane
7 Aug
4
Hoge Stephen
16 Jul
Beneficial Ownership
(44)
Expand
SC 13G
Moderna, Inc.
12 Aug
SC 13G/A
Moderna, Inc.
6 Aug
SC 13G/A
Moderna, Inc.
24 Jul
SC 13G
Moderna, Inc.
30 Apr
SC 13G/A
Moderna, Inc.
27 Mar
SC 13G/A
Moderna, Inc.
9 Feb
SC 13G/A
Moderna, Inc.
6 Feb
SC 13G
Moderna, Inc.
5 Feb
SC 13G/A
Moderna, Inc.
5 Nov 2025
SC 13G
Moderna, Inc.
12 May 2025
SC 13G/A
Moderna, Inc.
30 Apr 2025
SC 13G/A
Moderna, Inc.
12 Feb 2025
SC 13G/A
Moderna, Inc.
10 Apr 2024
SC 13G/A
Moderna, Inc.
13 Feb 2024
SC 13G/A
Moderna, Inc.
7 Feb 2024
Other Ownership
(161)
Expand
144
Hoge Stephen
15 Oct
144
Hoge Stephen
14 Oct
144
Hoge Stephen
15 Sep
144
Hoge Stephen
14 Sep
144
Mock James M
10 Sep
144
Klinger Shannon Thyme
1 Sep
144
Bancel Stephane
5 Aug
144
Hoge Stephen
15 Jul
144
SAGAN PAUL
18 Jun
144
Hoge Stephen
15 Jun
144
Klinger Shannon Thyme
4 Jun
144
Flagship Pioneering, LLC
21 May
144
Hoge Stephen
15 May
144
SAGAN PAUL
8 May
144
Hussain Abbas
1 May
Proxies
(28)
Expand
DEFA14A
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
16 Mar
DEF 14A
DEFINITIVE PROXY STATEMENT
16 Mar
ARS
ANNUAL REPORT TO SECURITY HOLDERS
16 Mar
DEFA14A
Definitive additional materials
20 Oct 2025
DEF 14A
Definitive proxy statement
15 Oct 2025
PRE 14A
OTHER PRELIMINARY PROXY STATEMENTS
3 Oct 2025
DEF 14A
DEFINITIVE PROXY STATEMENT
11 Mar 2025
ARS
ANNUAL REPORT TO SECURITY HOLDERS
11 Mar 2025
DEFA14A
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
11 Mar 2025
DEF 14A
Definitive proxy statement
21 Mar 2024
DEFA14A
Definitive additional materials
21 Mar 2024
ARS
Annual report to security holders
15 Mar 2024
PRE 14A
Preliminary proxy statement
11 Mar 2024
DEFA14A
Definitive additional materials
14 Apr 2023
PX14A6G
Notice of exempt solicitation
13 Apr 2023
Registrations
(23)
Expand
S-8
Registration statement (employee benefit plan)
20 Feb
S-8
Registration statement (employee benefit plan)
21 Feb 2025
S-8
Registration statement (employee benefit plan)
23 Feb 2024
S-3ASR
Automatic shelf registration statement (S-3)
5 May 2023
424B5
Prospectus filing (Rule 424(b)(5))
20 May 2020
S-3ASR
Automatic shelf registration statement (S-3)
18 May 2020
S-8
Registration statement (employee benefit plan)
27 Feb 2020
424B5
Prospectus filing (Rule 424(b)(5))
12 Feb 2020
FWP
Free writing prospectus
10 Feb 2020
FWP
Free writing prospectus
10 Feb 2020
S-3ASR
Automatic shelf registration statement (S-3)
10 Feb 2020
424B5
Prospectus filing (Rule 424(b)(5))
10 Feb 2020
S-8
Registration statement (employee benefit plan)
13 Mar 2019
424B4
Prospectus filing (Rule 424(b)(4))
7 Dec 2018
S-8
Registration statement (employee benefit plan)
7 Dec 2018
Filing Review Correspondence
(7)
Expand
CORRESP
Filing review correspondence
28 Apr 2023
CORRESP
Filing review correspondence
4 Dec 2018
CORRESP
Filing review correspondence
4 Dec 2018
CORRESP
Filing review correspondence
13 Nov 2018
CORRESP
Filing review correspondence
9 Nov 2018
DRSLTR
Filing review correspondence (DRSLTR)
31 Oct 2018
DRSLTR
Filing review correspondence (DRSLTR)
9 Oct 2018
SEC Orders And Notices
(2)
Expand
CT ORDER
Confidential treatment order
7 Dec 2018
EFFECT
Notice of effectiveness
6 Dec 2018
Tender Offers And Going Private
(8)
Expand
SC TO-I/A
Tender offer statement (issuer, amendment)
16 Dec 2025
SC TO-I/A
Tender offer statement (issuer, amendment)
18 Nov 2025
SC TO-I
Tender offer statement (issuer)
13 Nov 2025
SC TO-C
Tender offer statement (communication)
12 Nov 2025
SC TO-C
Tender offer statement (communication)
6 Nov 2025
SC TO-C
Tender offer statement (communication)
21 Oct 2025
SC TO-C
Tender offer statement (communication)
10 Oct 2025
SC TO-C
Tender offer statement (communication)
3 Oct 2025
Exempt Offerings
(1)
Expand
D
06b
24 Aug 2016
Other
(3)
Expand
SEC STAFF LETTER
SEC STAFF LETTER
16 Apr 2021
SEC STAFF LETTER
SEC STAFF LETTER
19 Mar 2021
CERT
CERT
7 Dec 2018
Ask in Filing